Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 2016

View Archived Issues

FDA grants QIDP designation to Amplyx Pharmaceuticals' APX-001

Bone Biologics signs agreement with UCLA to license Nell-1 for osteoporosis

QIAGEN launches QIAsure Methylation Test for cervical cancer

alpha-Synuclein specifically binds to TOM20 and inhibits mitochondrial protein import in human PD

Novel tracer targeting thymidine phosphorylase tested for the first time in humans

BARDA awards next option on contract to Atox Bio to support development of AB-103

PeptiDream earns milestone for the dosing of first patient in BMS clinical trial

Flex Pharma starts phase II study for FLX-787

Multilisa BICD2 test receives CE Mark

Roche patents cathepsin S inhibitors

Janssen Pharmaceutica discloses mGlu2 receptor negative allosteric modulators

Novartis expands partnership with MMV for the development of antimalarial compound KAF-156

Eli Lilly develops AICARFT inhibitors

Bayer Schering Pharma presents sGC activators

Aegerion Pharmaceuticals and QLT enter strategic merger agreement

Merck & Co. announces OX2 receptor antagonists

MRC Technology and AstraZeneca seek new epigenetic drug targets in respiratory disease

Oncolys BioPharma announces joint research agreement with Kyoto University

Argos Therapeutics and Adaptive Biotechnologies enter strategic research agreement

Zydus Cadila and Eczacibassi Ilac Pazarlama establish biosimilars strategic collaboration in Turkey

Worse progression-free survival seen in pelareorep treatment group in colorectal cancer trial

Long-term efficacy and safety of canakinumab

On-target activity and responses seen with BGB-324 in first study in leukemia patients

AnGes and Morishita Jintan enter agreement regarding rights to CIN treatment vaccine

FDA approves expanded label for Glassia

Apogenix reports topline results from phase I trial of APG-101

Cellceutix says phase II trial of brilacidin in ulcerative proctitis set to begin this week

Cibinetide receives two FDA orphan drug designations

TASP-0434299: a specific radioligand to vasopressin V1B receptor

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...